Prikaz osnovnih podataka o disertaciji
Uloga mTOR i MAPK signalnih puteva u rezistenciji karcinoma štitaste žlezde na hemioterapiju
The role of mTOR and MAPK signaling pathways in resistance of thyroid carcinoma to chemotherapy.
dc.contributor.advisor | Stamenković-Radak, Marina | |
dc.contributor.other | Banković, Jasna | |
dc.contributor.other | Tanić, Nikola | |
dc.contributor.other | Pešić, Milica | |
dc.contributor.other | Džodić, Radan | |
dc.creator | Milošević, Zorica | |
dc.date.accessioned | 2016-05-14T10:07:45Z | |
dc.date.available | 2016-05-14T10:07:45Z | |
dc.date.available | 2020-07-03T08:13:05Z | |
dc.date.issued | 2014-12-26 | |
dc.identifier.uri | https://nardus.mpn.gov.rs/handle/123456789/5283 | |
dc.identifier.uri | http://eteze.bg.ac.rs/application/showtheses?thesesId=2847 | |
dc.identifier.uri | https://fedorabg.bg.ac.rs/fedora/get/o:11053/bdef:Content/download | |
dc.identifier.uri | http://vbs.rs/scripts/cobiss?command=DISPLAY&base=70036&RID=1024938162 | |
dc.description.abstract | Kаrcinomi štitаste žlezde su nаjčešći mаligniteti endokrinog sistemа. Klаsifikаcijа ovih mаlignitetа je izvršenа nа osnovu njihovih histopаtoloških kаrаkteristikа nа pаpilаrni, folikulаrni medulаrni i аnаplаstični kаrcinom (ATC). Većinа karcinoma štitаste (...) | sr |
dc.description.abstract | Thyroid carcinoma is the most common malignancy of the endocrine system. Thyroid malignancies are classified according to their histopathological characteristic as papillary, follicular, medullary and anaplastic thyroid carcinoma (ATC). Most thyroid malign (...) | en |
dc.format | application/pdf | |
dc.language | sr | |
dc.publisher | Универзитет у Београду, Биолошки факултет | sr |
dc.relation | info:eu-repo/grantAgreement/MESTD/Integrated and Interdisciplinary Research (IIR or III)/41031/RS// | |
dc.rights | openAccess | en |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.source | Универзитет у Београду | sr |
dc.subject | Anaplastični karcinom štitaste žlezde (ATC) | sr |
dc.subject | Anaplastic thyroid cancer (ATC) | en |
dc.subject | RAS/MAPK/ERKpathway | en |
dc.subject | PI3K/AKT/mTOR pathway | en |
dc.subject | ATC chemoresistance | en |
dc.subject | ATC invasiveness | en |
dc.subject | dual mTOR inhibitor | en |
dc.subject | AZD2014 | en |
dc.subject | paclitaxel (PTX) | en |
dc.subject | PI3K/AKT/mTOR signаlni put | sr |
dc.subject | RAS/MAPK/ERK signаlni put | sr |
dc.subject | rezistencija ATC | sr |
dc.subject | invazivnost ATC | sr |
dc.subject | dvostruki mTOR inhibitor | sr |
dc.subject | AZD2014 | sr |
dc.subject | paklitaksel (PTX) | sr |
dc.title | Uloga mTOR i MAPK signalnih puteva u rezistenciji karcinoma štitaste žlezde na hemioterapiju | sr |
dc.title | The role of mTOR and MAPK signaling pathways in resistance of thyroid carcinoma to chemotherapy. | en |
dc.type | doctoralThesis | en |
dc.rights.license | BY-NC-ND | |
dcterms.abstract | Стаменковић-Радак, Марина; Джодић, Радан; Банковић, Јасна; Танић, Никола; Пешић, Милица; Милошевић, Зорица; Улога мТОР и МAПК сигналних путева у резистенцији карцинома штитасте жлезде на хемиотерапију; Улога мТОР и МAПК сигналних путева у резистенцији карцинома штитасте жлезде на хемиотерапију; | |
dc.identifier.fulltext | http://nardus.mpn.gov.rs/bitstream/id/2997/Disertacija957.pdf | |
dc.identifier.fulltext | https://nardus.mpn.gov.rs/bitstream/id/2997/Disertacija957.pdf | |
dc.identifier.fulltext | https://nardus.mpn.gov.rs/bitstream/id/2998/Zorica_Milosevic_Referat_BF.pdf | |
dc.identifier.fulltext | http://nardus.mpn.gov.rs/bitstream/id/2998/Zorica_Milosevic_Referat_BF.pdf | |
dc.identifier.rcub | https://hdl.handle.net/21.15107/rcub_nardus_5283 |